ATUL2019-07-012019-09-30in-bse-fin:OneOperatingExpenses01Member ATUL2019-07-012019-09-30in-bse-fin:OneOperatingExpenses02Member ATUL2019-07-012019-09-30in-bse-fin:FourOperatingExpenses01Member ATUL2019-07-012019-09-30in-bse-fin:FourOperatingExpenses02Member ATUL2019-07-012019-09-30in-bse-fin:OneReportableSegmentRevenue01Member ATUL2019-07-012019-09-30in-bse-fin:OneReportableSegmentRevenue02Member ATUL2019-07-012019-09-30in-bse-fin:OneReportableSegmentRevenue03Member ATUL2019-07-012019-09-30in-bse-fin:FourReportableSegmentRevenue01Member ATUL2019-07-012019-09-30in-bse-fin:FourReportableSegmentRevenue02Member ATUL2019-07-012019-09-30in-bse-fin:FourReportableSegmentRevenue03Member ATUL2019-07-012019-09-30in-bse-fin:OneReportableSegmentResults01Member ATUL2019-07-012019-09-30in-bse-fin:OneReportableSegmentResults02Member ATUL2019-07-012019-09-30in-bse-fin:OneReportableSegmentResults03Member ATUL2019-07-012019-09-30in-bse-fin:FourReportableSegmentResults01Member ATUL2019-07-012019-09-30in-bse-fin:FourReportableSegmentResults02Member ATUL2019-07-012019-09-30in-bse-fin:FourReportableSegmentResults03Member ATUL2019-07-012019-09-30in-bse-fin:OneReportableSegmentAssets01Member ATUL2019-07-012019-09-30in-bse-fin:OneReportableSegmentAssets02Member ATUL2019-07-012019-09-30in-bse-fin:OneReportableSegmentAssets03Member ATUL2019-07-012019-09-30in-bse-fin:OneReportableSegmentLiabilities01Member ATUL2019-09-30in-bse-fin:OneReportableSegmentLiabilities01Member ATUL2019-07-012019-09-30in-bse-fin:OneReportableSegmentLiabilities02Member ATUL2019-09-30in-bse-fin:OneReportableSegmentLiabilities02Member ATUL2019-07-012019-09-30in-bse-fin:OneReportableSegmentLiabilities03Member ATUL2019-09-30in-bse-fin:OneReportableSegmentLiabilities03Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares ATUL 2019-04-01 2020-03-31 2019-09-30 INR Crores Half yearly Multi segment 2019-07-01 2019-09-30 Unaudited Standalone 10130200000.00 244400000.00 10374600000.00 5089700000.00 27500000.00 -190200000.00 631800000.00 3500000.00 290000000.00 2432700000.00 8285000000.00 2089600000.00 0.00 2089600000.00 371200000.00 -365000000.00 6200000.00 0.00 2083400000.00 0.00 0.00 0.00 0.00 2083400000.00 -381100000.00 1702300000.00 0.00 0.00 296600000.00 10 70.24 70.26 0.00 0.00 70.24 70.26 Standalone unaudited financial results for the quarter / six months ended on September 30, 2019 nNotes:ttttttt ntttttttt n1.tThese results have been prepared in accordance with the Ind AS notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. ntttttttt n2.tThese results have been reviewed and recommended for adoption by the Audit Committee in its meeting held on October 24, 2019, and approved by the Board of Directors at its meeting held on October 25, 2019. The Statutory Auditors of the Company have carried out a limited review of the standalone unaudited financial results for the quarter / six months ended on September 30, 2019. The standalone unaudited cash flow statement for six months ended on September 30, 2018 have not been reviewed by the statutory auditors. Their limited review report does not have any qualification / modification. ntttttttt n3.tThe Company publishes standalone unaudited financial results along with the consolidated unaudited financial results. In accordance with the Indian Accounting Standard (Ind AS) 108, 'Operating Segments', the Company has disclosed the segment information in the consolidated unaudited financial results and therefore no separate disclosure on segment information is given in the standalone unaudited financial results for the quarter / six months ended on September 30, 2019. n4.tOther income includes: n(Rs. cr) nParticularstQuarter ended ontSix months ended ontYear nended on ntSeptember 30, 2019tJune 30, n2019tSeptember 30, 2018tSeptember 30, 2019tSeptember 30, 2018tMarch 31, n2019 ntUnauditedtUnauditedtUnauditedtUnauditedtUnauditedtAudited nExchange rate difference - gain / (loss)t 4.36 t (0.01)t 12.32 t 4.35 t 23.45 t 10.98 n n n5.tEffective April 01, 2019, the Company has adopted Ind AS 116 using the ‘Modified Retrospective Approach’. Upon transition, cumulative adjustment for present value of the remaining lease payments of lease contracts existing as on the date of initial application has been recognised as a lease liability with an equivalent asset for the right to use. The comparative information of previous year is not restated as permitted by the standard. The adoption of the standard did not have any material impact on these financial results. ntttttttt n6.tThe Company has adopted option available under section 115 BAA of the Income Tax Act, 1961 as introduced by the taxation laws (amendment) ordinance, 2019 dated September 20, 2019. Accordingly, tax expenses, deferred tax assets / liabilities as on September 30, 2019 have been recomputed and impact of this has been recognised in the quarter / six months ended on September 30, 2019. ntttttttt n7.tThe Board of Directors at its meeting held on October 25, 2019, has declared a special interim dividend of Rs. 12.50 per share. 2019-04-01 2019-09-30 Unaudited Standalone 20063200000.00 339800000.00 20403000000.00 10107100000.00 41900000.00 -286700000.00 1221100000.00 7600000.00 575300000.00 4673100000.00 16339400000.00 4063600000.00 0.00 4063600000.00 1036300000.00 -353400000.00 682900000.00 0.00 3380700000.00 0.00 0.00 0.00 0.00 3380700000.00 -829000000.00 2551700000.00 0.00 0.00 296600000.00 10 113.98 113.98 0.00 1.00 113.98 114.98 Other Expenses 1494500000.00 Power, Fuel and Water 938200000.00 Other Expenses 2895400000.00 Power, Fuel and Water 1777700000.00 Life Science Chemicals 3301100000.00 Others 129200000.00 Performance and Other Chemicals 7473400000.00 Life Science Chemicals 6799000000.00 Others 184700000.00 Performance and Other Chemicals 14801100000.00 10903700000.00 21784800000.00 447400000.00 923000000.00 10456300000.00 20861800000.00 Life Science Chemicals 623300000.00 Others 50100000.00 Performance and Other Chemicals 1420200000.00 Life Science Chemicals 1324800000.00 Others 61300000.00 Performance and Other Chemicals 2887900000.00 2093600000.00 4274000000.00 20300000.00 39000000.00 -50700000.00 -65800000.00 2124000000.00 4300800000.00 Life Science Chemicals 8466000000.00 Others 1246500000.00 Performance and Other Chemicals 17128200000.00 26840700000.00 11970900000.00 38811600000.00 Life Science Chemicals 2896300000.00 Others 389500000.00 Performance and Other Chemicals 4407400000.00 7693200000.00 1591400000.00 9284600000.00